Johnson & Johnson (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for an upfront payment of $600 million, subject to customary adjustments, with the potential for additional regulatory and commercial milestone payments up to approximately $1.1 billion. V-Wave will join Johnson & Johnson as part of Johnson & Johnson MedTech.
Read the full article: Johnson & Johnson to Acquire V-Wave //
Source: https://www.businesswire.com/news/home/20240820275047/en/Johnson-Johnson-to-Acquire-V-Wave